|
Volume 17 • Issue 16 |
September 6, 2017 |
|
|
|
|
|
|
|
IMPORTANT INFORMATION
DISCONTINUATION OF TUSSIONEX® TABLETS
(RESINATED HYDROCODONE WITH PHENYLTOLOXAMINE)
Sanofi-aventis Canada Inc. would like to inform you that Tussionex® tablets (Resinated hydrocodone with phenyltoloxamine) is discontinued due to supply issues.
Read more
|
|
|
|
|
|
IMPORTANT INFORMATION
DISCONTINUATION OF FLAGYSTATIN® VAGINAL CREAM
(METRONIDAZOLE, NYSTATIN)
Sanofi-aventis Canada Inc. would like to inform you that Flagystatin® vaginal cream (metronidazole, nystatin) is discontinued due to supply issues.
Read more
|
|
|
|
|
|
SUBOXONE IS COVERED IN YOUR PROVINCE
Indivior would like to remind you that SUBOXONE is covered in your province. Please consult the provincial drug formulary for more details. We also encourage you to learn how innoviCares may help your patients save on brand-name SUBOXONE.
|
|
|
|
|
|
|
|
IMPORTANT INFORMATION
Meet the Team of Bausch + Lomb Allergy Products!
Read more
|
|
|
|
|
|
|
HOW IS COLD-FX® DIFFERENT FROM OTHER GINSENG PRODUCTS?
COLD-FX® is different from other ginseng products. Its medicinal ingredient CVT‑E002®
consists primarily of polysaccharide extracts from North American ginseng.
Read more
|
|
|
|